Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of LABA and LAMA Effects on Oxygenation in COPD
NCT05927155Phase 3Completed
- Sponsor
- Erasmus Hospital
- Start
- Jun 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olodaterol, tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by Erasmus Hospital. Started Jun 2021; status: completed.
02
Drugs
olodateroltiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT05927155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05927155.